# Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis

> **NCT03145922** · — · UNKNOWN · sponsor: **National Jewish Health** · enrollment: 45 (estimated)

## Conditions studied

- Sarcoidosis
- Sarcoidosis, Pulmonary

## Interventions

- **OTHER:** Observational Study

## Key facts

- **NCT ID:** NCT03145922
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2021-01
- **Final completion:** 2026-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2020-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03145922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03145922, "Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03145922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*